Evofem Biosciences, Inc.

EVFM · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$741$580$2,769$7,732
Short-Term Investments$0$0$0$0
Receivables$9,832$5,738$1,126$6,449
Inventory$1,577$1,697$5,379$7,674
Other Curr. Assets$1,068$418$1,635$5,685
Total Curr. Assets$13,609$9,210$12,699$30,140
Property Plant & Equip (Net)$547$1,309$8,346$11,169
Goodwill$0$0$0$0
Intangibles$9,597$0$0$0
Long-Term Investments$0$0$800$800
Tax Assets$0$0$0$0
Other NC Assets$36$35$3,318$403
Total NC Assets$10,180$1,344$12,464$12,372
Other Assets$0$0$0$0
Total Assets$23,789$10,554$25,163$42,512
Liabilities
Payables$16,172$17,020$14,984$10,316
Short-Term Debt$45,878$43,268$65,684$108,926
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,807$7,851$6,727$7,719
Total Curr. Liab.$80,448$72,463$93,830$137,663
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$9,809$4,593$0$0
Total NC Liab.$14,598$4,601$3,133$4,424
Other Liabilities$0$0$0$0
Cap. Leases$89$105$5,444$6,756
Total Liabilities$95,046$77,064$96,963$142,087
Equity
Pref Stock$0$0$0$4,740
Common Stock$11$2$12$16
Retained Earnings-$897,664-$888,699-$938,694-$860,680
AOCI-$2,630-$849$49,527$5,089
Other Equity$0$0$0$0
Total Equity-$71,257-$66,510-$71,800-$99,575
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,789$10,554$25,163$42,512
Net Debt$45,137$42,688$62,915$101,194
Evofem Biosciences, Inc. (EVFM) Financial Statements & Key Stats | AlphaPilot